International Psoriasis Council
Advancing Knowledge. Improving Care.
Welcome and Introduction
Nicole Ward
PART ONE: LECTURES
Disease models for biomarker research
Nicole Ward
Psoriasis and psoriatic arthritis biomarkers
Vinod Chandran
Machine learning approaches for psoriasis research
Alex Tsoi
PANEL DISCUSSION
Johann Gudjonsson
PART TWO: POSTER PRESENTATIONS
Introduction to Session
Johann Gudjonsson
POSTER PRESENTATIONS
Transethnic analysis of psoriasis susceptibility in South Asians and Europeans enhances fine-mapping in the MHC and genomewide
James T. Elder, MD, PhD – University of Michigan, Ann Arbor, Michigan, United States
Single cell transcriptomic analysis of the peripheral neutrophil compartment in psoriatic arthritis reveals heterogeneity and novel potential therapeutic targets
Cheryl Cameron, PhD – Case Western Reserve University, Cleveland, Ohio, United States
Perspective of psoriatic disease patients on novel COVID-19 vaccines
George Gondo, MA – National Psoriasis Foundation, Portland, Oregon, United States
Comparing the pediatric and adult plaque psoriasis transcriptomes
Wynnis Tom, MD – University of California San Diego, San Diego, California, United States
Closing Comments
Johann Gudjonsson
In this IPC commentary, Matias Maskin examines evidence from the BADBIR registry demonstrating that first-line biologic therapy in moderate to severe psoriasis leads to faster skin clearance, improved quality of life, and a lower risk of comorbidities. The analysis challenges traditional step-up approaches and supports earlier, patient-centered treatment strategies.
What were the key takeaways from the 2026 AAD Annual Meeting? IPC shares updates on diagnostic challenges, psoriasis therapies, and late-breaking research from leading experts.
A new regional collaboration led by IPC and partner organizations aims to improve diagnosis, treatment, and care coordination for psoriasis and psoriatic arthritis across Latin America.
IPC recognizes its 2025 Fellows as IPC Jr. Councilors following the completion of their fellowship. This transition recognizes their contributions to psoriasis research, education, and global collaboration, and marks their expanded role in the IPC network.
The International Psoriasis Council welcomes Mari Løset and Maxwell Sauder as new Councilors, supporting IPC’s global mission in psoriasis research and care.
In this Take Ten with IPC video, Dr. Leandro Leite discusses the most recent advances in psoriasis over the last year (March 2025 – March 2026). Topics include new guidelines, research, and recent studies.
